Category: Cyst Risks

Humana leads Medicare Advantage ratings with 95% of members in four-star or higher plans, driving a 12% stock rise and beating J.P. Morgan’s forecast.

Ascension is selling its stake in Arizona insurer Mercy Care to CVS Pharmacy, according to its fiscal 2026 financial statement. The agreement was signed in July

UnitedHealthcare expands $0-premium Medicare Advantage options in 2027, covering 90% of eligible consumers in its service areas during open enrollment.

Dr. Neil Baum urges medical practices to adopt clear mission statements for consistent patient care and organizational direction.

Canada's healthcare crisis may cause preventable deaths due to long wait times and worsening health outcomes.

Canada’s drug approval delays now take 10-15 years post-approval, far outpacing NASA’s Artemis II moon mission speed of just 10 days.

Canadians urge urgent healthcare fixes as Parliament returns, with 89% prioritizing universal access amid prolonged wait times and staff shortages.

Lung cancer advocacy shines as former NFL linebacker Chris Draft shares his personal journey, supporting patients with resources and inspiration.

FDA approves BESREMi, a new treatment for essential thrombocythemia, providing fresh options for patients with this rare blood cancer.

FDA approves Rasonque, the first-in-class pancreatic cancer therapy targeting RAS mutations. Learn how this new oral treatment works for metastatic cancer.